Zydus Cadila

Zydus Cadila gets USFDA nod to market generic drug

Zydus Cadila gets USFDA nod to market generic drug

Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market Fluphenazine Hydrochloride ...Read More

Drug firm Zydus Cadila introduces scratch code in critical drug packs to fight counterfeit menace

Drug firm Zydus Cadila introduces scratch code in critical drug packs to fight counterfeit menace

Drug firm Zydus Cadila on Friday said it has introduced a new feature in the packaging of its critical drugs to help patients ensure that...Read More

Zydus Cadila launches drug for treatment of breast cancer

Zydus Cadila launches drug for treatment of breast cancer

Zydus Cadila on Monday launched Ujvira, a drug used for treatment of breast cancer.The company has launched Trastuzumab Emtansine, the fi...Read More

COVID-19 vaccine update: Zydus Cadila to make 5 crore dose by year-end; J&J is waiting for DCGI's approval to start local trials

COVID-19 vaccine update: Zydus Cadila to make 5 crore dose by year-end; J&J is waiting for DCGI's approval to start local trials

Drug maker Zydus Cadila plans to make five crore doses of its COVID-19 vaccine by the end of this year. At present, its COVID-19 vaccine ...Read More

Zydus Cadila to sell one of its animal health business for Rs 2,921 cr

Zydus Cadila to sell one of its animal health business for Rs 2,921 cr

Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset ...Read More

Zydus Cadila's 'Virafin' gets emergency use approval for treating moderate COVID-19 cases

Zydus Cadila's 'Virafin' gets emergency use approval for treating moderate COVID-19 cases

New Delhi: Zydus Cadila has received emergency use approval from the Drugs Controller General of India (DGCI) for the use of 'Virafin' in...Read More

Zydus gets  DCGI emergency use approval for Virafin to treat moderate COVID-19 cases

Zydus gets DCGI emergency use approval for Virafin to treat moderate COVID-19 cases

Zydus Cadila on Friday announced that the company had received Restricted Emergency Use Approval from the Drug Controller General of Indi...Read More

Zydus Cadila gets USFDA approval to market anti-arrhythmic drug

Zydus Cadila gets USFDA approval to market anti-arrhythmic drug

Pharmaceutical company Zydus Cadila, part of Cadila Healthcare Group on Friday said it has received final approval from the US health reg...Read More

COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir’s production

COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir’s production

Indian multinational pharmaceutical company Cipla, one of the manufacturers of Remdesvir in the country, stated that it scaled up product...Read More

Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

New Delhi: Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (D...Read More

Zydus Cadila seeks DCGI's approval for Pegylated Interferon alpha-2b, a single-dose COVID-19 treatment

Zydus Cadila seeks DCGI's approval for Pegylated Interferon alpha-2b, a single-dose COVID-19 treatment

After running trials with thousands of patients, Zydus Cadila’s drug Pegylated Interferon Alpha 2b, PegiHepTM has now gone before the Dru...Read More

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

PM's visit to Serum Institute: Here's why Uddhav Thackeray did not accompany Narendra Modi in Pune

PM's visit to Serum Institute: Here's why Uddhav Thackeray did not accompany Narendra Modi in Pune

Prime Minister Narendra Modi was on his three-city visit on Saturday to review coronavirus vaccine development work. Three major pharma p...Read More

PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila chairperson

PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila chairperson

"The scientists, all 18,000 of them and 25,000 plus Ziduns are continuously thriving and working for providing safe and efficacious vacci...Read More

Covishield, Covaxin & ZyCov-D top COVID-19 vaccine contenders. When will India get a vaccine?

Covishield, Covaxin & ZyCov-D top COVID-19 vaccine contenders. When will India get a vaccine?

In India, top contenders are Covishield, Covaxin and ZyCov-D. And, there is a new hope that India can get a vaccine soon. But, who will s...Read More

ICMR plans to launch indigenous COVID-19 vaccine by mid-August; experts remain skeptical

ICMR plans to launch indigenous COVID-19 vaccine by mid-August; experts remain skeptical

India's apex medical body ICMR said Friday that it aims to launch the world's first COVID-19 vaccine, the indigenously developed Covaxin,...Read More

Zydus Cadila's vaccine for COVID-19 completes pre-clinical development, to initiate human clinical trials

Zydus Cadila's vaccine for COVID-19 completes pre-clinical development, to initiate human clinical trials

Ahmedabad: Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously a...Read More

COVID-19 drug: After Zydus Cadila and Jubilant Life, Dr. Reddy's signs licensing agreement with Gilead Sciences for Remdesivir

COVID-19 drug: After Zydus Cadila and Jubilant Life, Dr. Reddy's signs licensing agreement with Gilead Sciences for Remdesivir

Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with American-based biopharmaceutical company, Gilead Scien...Read More

Daily production capacity of hydroxychloroquine is enough for current demand: Sudarshan Jain

Daily production capacity of hydroxychloroquine is enough for current demand: Sudarshan Jain

Many countries around the world are trying to get access to hydroxychloroquine, an anti-malarial drug, which is largely produced in India...Read More

Zydus Cadila boosts Hydroxychloroquine production 10 times to battle coronavirus

Zydus Cadila boosts Hydroxychloroquine production 10 times to battle coronavirus

India is the biggest manufacturer of hydroxychloroquine, the anti-malarial drug that is being touted as 'game-changer' in the fight again...Read More

Free Press Journal

www.freepressjournal.in